Skip to content

Opening book details…

About this Medicine article

Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial by Kappos, Ludwig (author);Arnold, Douglas L. (author);Bar-Or, Amit (author);Camm, John (author);Derfuss, Tobias (author);Kieseier, Bernd C. (author);Sprenger, Till (author);Greenough, Kristin (author);Ni, Pingping (author);Harada, Tomohiko (author) is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Kappos, Ludwig (author);Arnold, Douglas L. (author);Bar-Or, Amit (author);Camm, John (author);Derfuss, Tobias (author);Kieseier, Bernd C. (author);Sprenger, Till (author);Greenough, Kristin (author);Ni, Pingping (author);Harada, Tomohiko (author)
Publisher
Lancet Publishing Group
Published
2016
Field
Medicine (Health Sciences)

More by Kappos, Ludwig (author);Arnold, Douglas L. (author);Bar-Or, Amit (author);Camm, John (author);Derfuss, Tobias (author);Kieseier, Bernd C. (author);Sprenger, Till (author);Greenough, Kristin (author);Ni, Pingping (author);Harada, Tomohiko (author)

Browse all works by Kappos, Ludwig (author);Arnold, Douglas L. (author);Bar-Or, Amit (author);Camm, John (author);Derfuss, Tobias (author);Kieseier, Bernd C. (author);Sprenger, Till (author);Greenough, Kristin (author);Ni, Pingping (author);Harada, Tomohiko (author)